Company Filing History:
Years Active: 2022-2025
Title: Brent M Dorr: Innovator in Biocatalysis
Introduction
Brent M Dorr is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of biocatalysis, particularly through his work on engineered carboxyesterase enzymes. With a total of 2 patents, Dorr's innovations are paving the way for advancements in amide bond formation.
Latest Patents
Dorr's latest patents focus on carboxyesterase biocatalysts. The present disclosure provides engineered carboxyesterase enzymes that have the ability to catalyze amide bond formation. Additionally, it includes polynucleotides encoding the carboxyesterase enzymes, host cells capable of expressing these engineered enzymes, and methods for using them to create commercially valuable amides. The patents also detail the amides produced using these engineered carboxyesterase enzymes.
Career Highlights
Brent M Dorr is associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to innovate in the field of biocatalysis. His work has been instrumental in developing new methods for synthesizing valuable compounds.
Collaborations
Dorr collaborates with talented coworkers, including Kristin K Brown and Douglas E Fuerst. Their combined expertise enhances the innovative environment at GlaxoSmithKline.
Conclusion
Brent M Dorr's contributions to biocatalysis through his patented inventions are significant. His work not only advances scientific understanding but also has practical applications in the industry.